Biohaven BHVN
NYSE BHVN
$15.69 -0.17 (-1.07%)
As of: Sep 4, 2026 · 3:59 PM EDT

Biohaven (BHVN) Depreciation & Amortization (CF) (2021 - 2026)

Biohaven (BHVN) posted Depreciation & Amortization (CF) of $2.4 million for Q1 2026, down 8.05% sequentially from $2.6 million in Q4 2025, and up 5.34% YoY from $2.2 million in Q1 2025.

Analysis

Biohaven (BHVN) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends

Biohaven has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $2.4 million in Q1 2026.

  • Quarterly Depreciation & Amortization (CF) rose 5.34% year-over-year to $2.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.0 million (up 16.03% YoY) and the FY2025 annual result came in at $9.9 million, up 26.31% from the prior year.
  • Depreciation & Amortization (CF) eased to $2.4 million in Q1 2026 per BHVN's latest filing, from $2.6 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $3.1 million in Q3 2025 and troughed at $250000.0 in Q1 2022.
  • A 5-year average of $1.7 million and a median of $1.9 million in 2023 frame the typical range for Depreciation & Amortization (CF).
  • The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) slumped 49.78% in 2022, then soared 559.6% in 2023.
  • Over 5 years, Depreciation & Amortization (CF) stood at $344000.0 in 2022, then jumped by 450.58% to $1.9 million in 2023, then advanced by 29.94% to $2.5 million in 2024, then climbed by 4.55% to $2.6 million in 2025, then dropped by 8.05% to $2.4 million in 2026.
  • According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $2.4 million, $2.6 million, and $3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 56.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 123.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 40.52 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Biohaven 2.37 Bn 2.10 Bn - 2.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.26 Mn
Mar 31, 2026 2.37 Mn
Dec 31, 2025 2.57 Mn
Sep 30, 2025 3.13 Mn
Jun 30, 2025 1.98 Mn
Mar 31, 2025 2.25 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 1.95 Mn
Mar 31, 2024 1.45 Mn
Dec 31, 2023 1.89 Mn
Sep 30, 2023 1.54 Mn
Jun 30, 2023 1.83 Mn
Mar 31, 2023 1.65 Mn
Dec 31, 2022 344,000.00
Sep 30, 2022 377,000.00
Jun 30, 2022 415,000.00
Mar 31, 2022 250,000.00
Dec 31, 2021 685,000.00